Skip to main content

Reimbursement

24
Jan 2023

New cardiovascular device categories proposed for the 2023/24 High Cost Device List in England

In December 2022, NHS England launched a consultation on the preliminary 2023/25 NHS Payment Scheme, which is set for two years and will replace the National Tariff Payment System from April 2023. Two new cardiovascular categories (antibacterial envelope, mitral valve repair and replacement devices) are proposed for inclusion in the 2023/24 High Cost Device List (will be updated and reissued for 2024/25). The deadline for comments submission is January 27, 2023.
23
Jan 2023

Three more health apps obtained reimbursement in Germany

On December 26, 2022, three more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by sickness funds.
19
Jan 2023

2023 NordDRG published in Finland

On January 1, 2023, the annual update of the Finnish NordDRG system came into force. There are 947 DRGs in the 2023 DRG system, compared to 930 DRGs in 2022. Among other changes, 34 new DRGs were introduced, including the DRGs in the cardiovascular, endocrine, endoscopy, gastrointestinal, obstetrics and gynecology, orthopedics, peripheral vascular, surgical procedures, and some other fields.
18
Jan 2023

2023 Pathology Activity Codes (APAT) system and reimbursement tariffs released in Norway

In January 2023, the updated Pathology Activity Codes (APAT) of the Norwegian Pathology Code system (NORPAT) came into force. Since 2022, APAT codes have been included in the new reimbursement scheme by Helfo (the Norwegian Health Economics Administration) for outpatient pathology services. Five new classified sample materials for cytology and 22 new additional codes for the method of testing were added to the scheme in 2023.
13
Jan 2023

Recommendations about add-on reimbursement for medical devices in France in December 2022

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in December 2022. Nine recommendations were published in relation to the registration, modification of registration conditions, and renewal of registration for devices in the List of reimbursable products and services (LPPR). Opinions concern the device used for neuromodulation, the device for the treatment of benign prostatic hyperplasia, orthopedic devices, as well as medical aids.
09
Jan 2023

New procedure codes added to the private reimbursement schedule in England

In December 2022, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclatures for private payers in England, published Bulletin 187 with changes to be implemented in procedural classification no later than February 8, 2023. Five new procedure codes were introduced concerning orthopedic, surgical procedures, and men’s health. No changes were made to the diagnostic schedule.
05
Jan 2023

NHS Digital released HRG4+ Consultation Grouper for 2023/24 in England

On December 19, 2022, NHS Digital released HRG4+ Consultation Grouper for 2023/24 to support NHS England’s consultation process for the 2023/25 NHS Payment Scheme. There are no new HRGs or other significant changes in the 2023/24 Consultation Grouper. Local Payment Grouper will supersede Consultation Grouper in March 2023 for use from April 1, 2023.